Demographic data of the 3233 patients on presentation
| HBeAg, hepatitis B e antigen; anti-HBe, antibody to hepatitis B e antigen; ALT, alanine aminotransferase; ULN, upper limit of normal; AFP, α fetoprotein. | |
| No of patients | 3233 |
| Sex ratio (M:F) | 2121:1112 (1.9:1) |
| Age (y) (median (range)) | 38 (1–85) |
| HBeAg: anti-HBe | 1274:1959 (1:1.5) |
| Albumin (g/l) (median (range)) | 45 (15–58) |
| Bilirubin (μmol/l) (median (range)) | 11.8 (1–55.3) |
| ALT (U/l) (median (range)) | 42 (4–4820) |
| No of patients with | |
| ALT ⩽0.5× ULN | 714 (22.1%) |
| ALT >0.5–1× ULN | 1006 (31.1%) |
| ALT 1–2× ULN | 737 (22.8%) |
| ALT >2–6× ULN | 479 (14.8%) |
| ALT >6× ULN | 297 (9.2%) |
| No of patients with | |
| AFP ⩽20 ng/ml | 2861 (88.5%) |
| AFP >20–100 ng/ml | 243 (7.5%) |
| AFP >100–500 ng/ml | 97 (3%) |
| AFP >500 ng/ml | 32 (1%) |
| Duration of follow up (months) | |
| Median (range) | 29 (6–291) |
| Mean (SD) | 46.9 (46.6) |